Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Lung inflammatory injury and tissue repair (Jul 2023)
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI119758

Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression.

U Dirksen, R Nishinakamura, P Groneck, U Hattenhorst, L Nogee, R Murray, and S Burdach

Department of Pediatrics, Children's Hospital Medical Center, Heinrich Heine University, Düsseldorf, Germany.

Find articles by Dirksen, U. in: JCI | PubMed | Google Scholar

Department of Pediatrics, Children's Hospital Medical Center, Heinrich Heine University, Düsseldorf, Germany.

Find articles by Nishinakamura, R. in: JCI | PubMed | Google Scholar

Department of Pediatrics, Children's Hospital Medical Center, Heinrich Heine University, Düsseldorf, Germany.

Find articles by Groneck, P. in: JCI | PubMed | Google Scholar

Department of Pediatrics, Children's Hospital Medical Center, Heinrich Heine University, Düsseldorf, Germany.

Find articles by Hattenhorst, U. in: JCI | PubMed | Google Scholar

Department of Pediatrics, Children's Hospital Medical Center, Heinrich Heine University, Düsseldorf, Germany.

Find articles by Nogee, L. in: JCI | PubMed | Google Scholar

Department of Pediatrics, Children's Hospital Medical Center, Heinrich Heine University, Düsseldorf, Germany.

Find articles by Murray, R. in: JCI | PubMed | Google Scholar

Department of Pediatrics, Children's Hospital Medical Center, Heinrich Heine University, Düsseldorf, Germany.

Find articles by Burdach, S. in: JCI | PubMed | Google Scholar

Published November 1, 1997 - More info

Published in Volume 100, Issue 9 on November 1, 1997
J Clin Invest. 1997;100(9):2211–2217. https://doi.org/10.1172/JCI119758.
© 1997 The American Society for Clinical Investigation
Published November 1, 1997 - Version history
View PDF
Abstract

Pulmonary alveolar proteinosis (PAP) is a heterogeneous disorder of genetic or acquired etiologies. In some cases congenital PAP is associated with hereditary surfactant protein (SP)-B deficiency. To date, the molecular defect in the majority of patients with PAP has not been identified. In mice, PAP has been generated by targeted deletion of the genes for either the GM-CSF/IL-3/IL-5 receptor common beta chain (beta c) or GM-CSF. Here, we describe an expression defect of beta c in three of seven pediatric patients with PAP and in one patient with severe lung disease suspected to be PAP. The patients failed to express normal levels of beta c as shown by flow cytometry. Strikingly reduced or absent function of beta c was demonstrated by ligand binding studies and progenitor clonogenic assays. Analysis of beta c DNA revealed a point mutation from proline to threonine at codon 602 in one patient. Our findings provide evidence that a defect in the expression of a hematopoietic cytokine receptor is associated with human PAP.

Version history
  • Version 1 (November 1, 1997): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts